BIOMAT Database Logo BIOMAT Database Logo

Once-daily verapamil in the treatment of mild-to-moderate hypertension: a double-blind placebo-controlled dose-ranging study. 1991

A A Carr, and P B Bottini, and L M Prisant, and L D Fisher, and J G Devane, and D E O'Brien, and R B Rhoades
Medical College of Georgia, School of Medicine, Department of Medicine, Augusta 30912-3150.

Supine office blood pressures (SOBP) and 24-hour automated ambulatory blood pressure monitorings (AABPM) showed blood pressure reductions from a stable baseline to active treatment with 120-, 240-, and 480-mg doses of a new verapamil QD capsule (solid-spheroidal-oral once-daily drug-absorption system: (SODAS) in patients with mild-to-moderately severe (diastolic blood pressures 95-119 mm Hg) essential hypertension. Reductions were documented at 24 hours, hourly, and by the 24 hour average, using SOBP and AABPM, after the once-daily verapamil administration. Both SOBP and the 24-hour average by AABPM were significantly reduced from baseline by active verapamil treatment of 120-, 240-, and 480-mg doses. In comparison to verapamil QD (0 mg), blood pressure reductions from baseline to active treatment were significant at the 240- and 480-mg doses but not at the 120-mg dose. There was a significant linear dose response. This verapamil formulation (SODAS) was effective throughout the 24-hour period after once-daily dosing.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A A Carr, and P B Bottini, and L M Prisant, and L D Fisher, and J G Devane, and D E O'Brien, and R B Rhoades
Barnidipine, a novel calcium antagonist for once-daily treatment of hypertension: a multicenter, double-blind, placebo-controlled, dose-ranging study. Dutch Barnidipine Multicenter Study Group.
November 1997, Cardiovascular drugs and therapy,
A A Carr, and P B Bottini, and L M Prisant, and L D Fisher, and J G Devane, and D E O'Brien, and R B Rhoades
Once daily treatment of mild to moderate hypertension with xipamid: a controlled study.
June 1977, British journal of clinical pharmacology,
A A Carr, and P B Bottini, and L M Prisant, and L D Fisher, and J G Devane, and D E O'Brien, and R B Rhoades
Efficacy and safety of once-daily inhaled ciclesonide in adults with mild to moderate asthma: a double-blind, placebo-controlled study.
July 2007, Respirology (Carlton, Vic.),
A A Carr, and P B Bottini, and L M Prisant, and L D Fisher, and J G Devane, and D E O'Brien, and R B Rhoades
Double-blind, placebo-controlled study of ramipril in diabetics with mild to moderate hypertension.
January 1993, Clinical therapeutics,
A A Carr, and P B Bottini, and L M Prisant, and L D Fisher, and J G Devane, and D E O'Brien, and R B Rhoades
Pranidipine, a novel calcium antagonist, once daily, for the treatment of hypertension: a multicenter, double-blind, placebo-controlled dose-finding study.
March 1996, Cardiovascular drugs and therapy,
A A Carr, and P B Bottini, and L M Prisant, and L D Fisher, and J G Devane, and D E O'Brien, and R B Rhoades
Once daily propranolol in the treatment of mild to moderate hypertension: a dose range finding study.
November 1978, European journal of clinical pharmacology,
A A Carr, and P B Bottini, and L M Prisant, and L D Fisher, and J G Devane, and D E O'Brien, and R B Rhoades
Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
June 1987, International journal of clinical pharmacology, therapy, and toxicology,
A A Carr, and P B Bottini, and L M Prisant, and L D Fisher, and J G Devane, and D E O'Brien, and R B Rhoades
A placebo-controlled double-blind multicenter study of celiprolol in the treatment of mild and moderate hypertension.
January 1986, Journal of cardiovascular pharmacology,
A A Carr, and P B Bottini, and L M Prisant, and L D Fisher, and J G Devane, and D E O'Brien, and R B Rhoades
Low-dose nitrendipine in mild hypertension: a double-blind, placebo-controlled, comparative study.
January 1991, Journal of cardiovascular pharmacology,
A A Carr, and P B Bottini, and L M Prisant, and L D Fisher, and J G Devane, and D E O'Brien, and R B Rhoades
Atenolol vs. amiloride-hydrochlorothiazide in the treatment of mild to moderate hypertension: a double-blind, crossover, placebo-controlled study.
January 1987, Drug intelligence & clinical pharmacy,
Copied contents to your clipboard!